12:00 AM
 | 
Jul 01, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Actavis, Mylan, Teva Pharmaceutical Industries Ltd, Pfizer sales and marketing update

Actavis, Mylan and Teva each launched generic versions of Pfizer's erectile dysfunction (ED) drug Viagra sildenafil in the EU immediately after Pfizer's patents covering Viagra expired. Actavis launched its generic in Austria, Denmark, France, Germany,...

Read the full 163 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >